Capital expenditures were $172 million, down from $288 million, focused on lab and manufacturing investments in the US and Asia.
Customer Support Business Group revenue was approximately $1.7 billion, consistent with prior quarters, with a third consecutive record quarter for upgrade revenue.
Deferred revenue balance increased by approximately $670 million from the prior quarter to $2.68 billion, related to advanced payments from newer customers.
Earnings per share were $1.33, exceeding the high end of guidance due to higher revenue, strong gross margin, and a lower tax rate of 4.8%.
Fiscal year 2025 revenue was a record $18.4 billion with a gross margin of 48.8%, and free cash flow was approximately $5.4 billion or 29% of revenue.
Gross margin reached 50.3%, the highest since the Lam-Novellus merger, and operating margin was 34.4%, near the high end of guidance.
Headcount increased by approximately 400 employees, primarily in R&D and manufacturing support.
Inventory turns improved to 2.4x from 2.2x, and days sales outstanding decreased to 59 days from 62 days.
Lam Research delivered revenues of $5.17 billion in the June 2025 quarter, a 10% increase from the prior quarter.
Regional revenue composition included 35% from China (up from 31%), 22% from Korea, 19% from Taiwan, and a record 14% from Japan.